press

PureTalk AI Collaborates with Plato AI to Launch Innovative WebApp Empowering Conversational AI.

November 7, 2023. New York, NY – Puretalk AI, a leading provider of advanced conversational AI solutions, is thrilled to announce its exciting collaboration with Plato, a pioneer in machine learning and AI technology. Together, they are launching a cutting-edge website Widget designed to revolutionize the way websites engage with visitors. This groundbreaking widget, which leverages Puretalk AI's machine learning capabilities and humanized Text-to-Speech (TTS+) technology, will transform static websites into interactive, conversational platforms. The new website Widget, aptly named "Socrates," has been engineered to dynamically learn and adapt to

Verofax wins GITEX Supernova Web3 & Blockchain Award 2023

DUBAI, Nov 1, 2023 - (ACN Newswire) - Verofax, an innovator in Brand & Retail solutions, was selected among 521 startups globally as the best solution offering for Web3 & Blockchain, at the GITEX 2023 Expo,  Supernova Challenge in Dubai. Verofax, a UAE-based startup and service provider for turning shopping & products interactive, has emerged as the winner of the 2023 Supernova Challenge at Expand North Star Dubai, the world's largest startup event. The startup received the prize after rounds of pitching against global finalists. Verofax's groundbreaking solution combines interactive Product

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

K10 Esports Embarks on a Revolutionary Journey: From Championships to the TCG World Metaverse.

An Exciting New Frontier for Esports Fans and Gamers Alike London, England. October 6, 2023. In a groundbreaking move that promises to redefine the esports landscape, the globally-renowned K10 Esports announces its next venture: diving into the world of the Metaverse with TCG World. As they continue their relentless pursuit of glory in games such as CS2, Valorant, and many more titles to come, K10 is now set to offer fans an unprecedented immersive experience by streaming their matches live in virtual venues within the TCG World Metaverse. This pioneering

Zilliqa partners with GMEX ZERO13 to launch consumer-focused carbon offset platform

  LONDON, 27 September 2023 – Zilliqa, a leading layer-1 blockchain offering high-performance, high-security and low-fee solutions, today announces a partnership with GMEX Group and its initiative ZERO13, the digital climate fintech aggregation ecosystem, to launch the first-of-its-kind carbon offset platform that will transform the way that retail customers engage with corporate environmental initiatives. Together, Zilliqa Group and GMEX ZERO13 will deliver a cutting-edge platform that uses the blockchain-based currency, EVP, to represent carbon credit offsets. When they purchase goods or services, customers of brands partnered with Zilliqa will receive

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Ex-Singapore Parliamentarian’s Swiss Company Launches Swiss Franc and Euro Stablecoins

Singapore investor and former parliamentarian Calvin Cheng's newly rebranded Swiss company, Anchored Coins, was granted membership in the Swiss VQF in early 2023. VQF is the largest and oldest cross-industry self-regulatory organisation in Switzerland and is officially recognised by FINMA, the country's financial services watchdog. Anchored Coins is launching a Swiss Franc-backed stablecoin (ACHF) and a Euro-backed stablecoin (AEUR), and will be issued on the Ethereum and BNB Chain blockchains. DCS Card Centre in Singapore is planning to issue credit cards collateralised by AEUR and ACHF. ZURICH, SWITZERLAND, Aug 16,

Goverment Liason – Sandy

Sandy Barsky Appointed as Government Liaison for the Blockchain & Infrastructure, the Rise of AI Conference. Washington, DC - [July 10, 2023] - The Government Blockchain Association (GBA) is thrilled to announce the appointment of Sandy Barsky as the Government Liaison for the upcoming Blockchain & Infrastructure, the Rise of AI Conference. The event is scheduled to take place on September 28-29, 2023, in Washington, DC. With an extensive background in the field, Sandy Barsky brings a wealth of experience to his new role. Having worked for decades at the

Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)

Washington DC, July 6th, 2023. Government Blockchain Association (GBA) announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the GBA Members Site. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption, standards and regulatory compliance of global government blockchain initiatives. Through this deployment GBA’s community will immediately benefit by accessing the latest premium intelligence across 36 Market Verticals including Ai, Digital Assets, Regulatory Initiatives, Web3, NFT’s, CyberSecurity, ESG and Carbon Offsets.